Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Adenocarcinoma 1

Interventions

pembrolizumab 35 Magnetic Resonance Spectroscopy 32 Specimen Handling 31 Carboplatin 24 Radiotherapy 22 Biopsy 21 Nivolumab 20 Radiation 19 Cisplatin 19 Cyclophosphamide 18 Paclitaxel 17 Doxorubicin 14 Radiotherapy, Intensity-Modulated 13 Bevacizumab 13 olaparib 12 Leucovorin 12 Docetaxel 12 durvalumab 11 Taxes 11 Gemcitabine 11 Disulfides 11 Dexamethasone 11 Vincristine 10 Radiosurgery 10 Prednisone 10 Pemetrexed 10 Immunoglobulin G 10 Fluorouracil 9 Etoposide 9 enzalutamide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × paricalcitol × 30 days × Clear all

NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed

34 enrolled 11 charts

Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡